*Invitation Only – Understanding the Impact of the US Presidential Election on Healthcare Policy and Global Business

*Invitation Only
*In-person program in Tokyo

Please join us for a breakfast program on Tuesday, Nov. 12 featuring an insightful discussion on the implications of the 2024 US Presidential Election for healthcare policy and business worldwide. This exclusive event will feature prominent experts from the healthcare and legal sectors:

• Glenn Snyder, Principal at Deloitte, specializing in life sciences and healthcare innovation
• Seth Flaum, Partner at Wilson Sonsini, a leading expert in regulatory law and healthcare business strategy

The session will be moderated by Makoto (Mark) Kawai. Mark is the Government Affairs Director at Zimmer Bionet in Japan, and serves as the chair of the Healthcare Committee and the Government Relations Committee at the American Chamber of Commerce in Japan (ACCJ).

With the election of either a Trump or Harris administration, the global healthcare landscape is poised for significant shifts. Our panel will explore key questions, including potential changes to regulatory frameworks, drug pricing policies, and healthcare reform initiatives in the US, and how these developments could affect global markets, including Japan and other key regions.

This timely discussion will provide valuable insights for healthcare leaders, policymakers, and business executives navigating the evolving landscape. Don’t miss this opportunity to hear from industry leaders about the future of healthcare in the US and beyond.

Our Amazing Speakers

Glenn Snyder | Principal, Lifesciences Strategy Deloitte Consuling, LLP

Glenn Snyder is a Principal with Deloitte Consulting, LLP. He leads Deloitte’s Global Medical Technology practice. Glenn has been serving the life sciences and healthcare industry as a consultant since 1989 and has been with Deloitte since 1995, tackling issues and opportunities across the healthcare value chain over the course of his career, including the payor and provider sectors. His expertise is within strategy discipline, specifically having helped clients evolve their business models and solutions through digital transformation, and grow through innovation and/or market expansion.

Glenn holds a Master of Business Administration in Finance and Strategic Management from the Wharton School of the University of Pennsylvania, a Master of Science in Engineering from the University of Southern California, and a Bachelor of Science in Engineering from Cal Poly, San Luis Obispo.

_S

Seth Flaum | Partner, Wilson Sonsini Goodrich & Rosati 

Seth Flaum is a partner in the New York office of Wilson Sonsini Goodrich & Rosati and a member of the technology transactions practice. With more than 25 years of broad transactional experience, he represents life sciences companies in a wide range of strategic transactions and corporate matters.

Prior to joining the firm, Seth was executive associate general counsel for Daiichi Sankyo, Inc., a global pharmaceutical company based in Japan, where he advised on an array of strategic transactions and managed a team of lawyers and business professionals responsible for implementing the company’s global business development transactions. In this role, Seth counseled on strategic transactions, collaborations, licensing agreements, research and development agreements, and other commercialization related transactions. He also has experience with public and private M&A transactions, and has advised on antitrust issues and filings, FINRA inquiries, SEC filings, and corporate governance matters.

Before joining Daiichi Sankyo, Seth was a senior associate at Ullman, Shapiro & Ullman, LLP in New York.

Makoto (Mark) D. Kawai | Healthcare Committee and the Government Relations Committee, American Chamber of Commerce in Japan (ACCJ) 

Born in Toronto. Graduated from Univ. of Toronto, Canada (M Eng.). Joined R&D Product Safety & Regulatory Affairs of P&G. After working 23 years for P&G, joined Zimmer Biomet as Government Affairs Director in October 2018. From early age at P&G, Mark has been shaping regulations, mainly healthcare regulations, in ways to helps consumers and leading efforts to work effectively & efficiently by leveraging digital technologies. 

Mark has passion in nourishing talents, shaping rules, and developing cultures for the future. He started up a program to develop globally capable leaders at University of Hyogo in 2013 and teaching at other universities since then. He also helped local governments by organizing training programs for their officers and by serving on various committees. 

He is now promoting changes in the Healthcare sector by leverage digital technologies that allows to increase quality/efficiency of healthcare services and to promote innovation with a strong believe that Japan can become a destination for Healthcare Innovation. 

Mark currently serves as the chair of the Healthcare Committee and the Government Relations Committee at the American Chamber of Commerce in Japan (ACCJ).